JPMorgan Chase & Co’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,944
| Closed | -$38.1K | – | 6705 |
|
2024
Q4 | $38.1K | Buy |
1,944
+1,764
| +980% | +$34.6K | ﹤0.01% | 5086 |
|
2024
Q3 | $2.82K | Buy |
180
+160
| +800% | +$2.51K | ﹤0.01% | 5509 |
|
2024
Q2 | $169 | Sell |
20
-1,274
| -98% | -$10.8K | ﹤0.01% | 5784 |
|
2024
Q1 | $20K | Sell |
1,294
-432
| -25% | -$6.67K | ﹤0.01% | 5236 |
|
2023
Q4 | $23.8K | Sell |
1,726
-324
| -16% | -$4.47K | ﹤0.01% | 5206 |
|
2023
Q3 | $23.4K | Sell |
2,050
-525
| -20% | -$6K | ﹤0.01% | 5113 |
|
2023
Q2 | $64.1K | Sell |
2,575
-1,719
| -40% | -$42.8K | ﹤0.01% | 4802 |
|
2023
Q1 | $156K | Buy |
4,294
+1,244
| +41% | +$45.2K | ﹤0.01% | 4452 |
|
2022
Q4 | $184K | Sell |
3,050
-463
| -13% | -$27.9K | ﹤0.01% | 4247 |
|
2022
Q3 | $264K | Sell |
3,513
-812
| -19% | -$61K | ﹤0.01% | 4048 |
|
2022
Q2 | $496K | Sell |
4,325
-1,254
| -22% | -$144K | ﹤0.01% | 3869 |
|
2022
Q1 | $1.06M | Sell |
5,579
-21,486
| -79% | -$4.07M | ﹤0.01% | 3573 |
|
2021
Q4 | $9.39M | Buy |
27,065
+21,258
| +366% | +$7.37M | ﹤0.01% | 2139 |
|
2021
Q3 | $1.95M | Buy |
5,807
+5,805
| +290,250% | +$1.95M | ﹤0.01% | 3200 |
|
2021
Q2 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 5384 |
|